Cytoprotection by iloprost against paracetamol‐induced toxicity in hamster isolated hepatocytes

1 The ability of iloprost (ZK36374) to protect hamster isolated hepatocytes from the toxic effects of paracetamol and its reactive metabolite N‐acetyl‐p‐benzoquinoneimine (NABQI) was investigated. The cytoprotection provided by iloprost was compared with that of N‐acetyl‐l‐cysteine. 2 Treatment of h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 1992-02, Vol.105 (2), p.417-423
Hauptverfasser: Nasseri‐Sina, P., Fawthrop, D.J., Wilson, J., Boobis, A.R., Davies, D.S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 423
container_issue 2
container_start_page 417
container_title British journal of pharmacology
container_volume 105
creator Nasseri‐Sina, P.
Fawthrop, D.J.
Wilson, J.
Boobis, A.R.
Davies, D.S.
description 1 The ability of iloprost (ZK36374) to protect hamster isolated hepatocytes from the toxic effects of paracetamol and its reactive metabolite N‐acetyl‐p‐benzoquinoneimine (NABQI) was investigated. The cytoprotection provided by iloprost was compared with that of N‐acetyl‐l‐cysteine. 2 Treatment of hepatocytes with either NABQI (0.4 mm) or paracetamol (2 mm) alone resulted in a considerable loss of cell viability, as assessed by trypan blue exclusion or leakage of lactate dehydrogenase, accompanied by an increase in the percentage of viable cells that were blebbed. N‐acetyl‐l‐cysteine (1.25 mm) pretreatment diminished the loss of cell viability and the percentage of blebbed cells resulting from exposure to NABQI or paracetamol, whereas iloprost (10−16 m to 10−10 m) pretreatment reduced only the loss of cell viability, not the percentage of viable cells exhibiting blebbing. Pretreatment with N‐acetyl‐l‐cysteine significantly attenuated the depletion by paracetamol of glutathione and decreased the covalent binding of [14C]‐paracetamol to cellular proteins, whereas iloprost was without any such effects. 3 The effects of iloprost and N‐acetyl‐l‐cysteine were also investigated by use of a model of paracetamol toxicity in which it is possible to study the biochemical events leading to cell injury separate from the generation of toxic metabolites. Hamster hepatocytes were incubated with paracetamol (4 mm) for 90 min at 37°C during which metabolism of paracetamol occurs with minimal loss of cell viability. Following washing of cells, to remove paracetamol and its metabolites, there was a progressive loss of viability and increase in the percentage of cells exhibiting blebbing when incubated in buffer alone. Addition of either N‐acetyl‐l‐cysteine (1.25 mm) or iloprost (10−14 m to 10−8 m), following washing, significantly reduced the expected loss of cell viability. Iloprost at concentrations outside this range was without effect. 4 Paracetamol toxicity to isolated hepatocytes could be prevented or delayed by treatment with either N‐acetyl‐l‐cysteine or iloprost, but whereas the former prevented or even reversed plasma membrane blebbing with a resultant reduction in the percentage of viable cells that were blebbed, the prostanoid appeared only to delay the progression from plasma membrane blebbing to loss of viability. Hence, the percentage of viable cells that were ultimately blebbed following exposure to paracetamol was not significantly reduced by addition of ilop
doi_str_mv 10.1111/j.1476-5381.1992.tb14268.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16189145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5388-fd1ca1690beed53c101ebfa4ed1c7f4edf4a5af4a8ce50558541d5bfa30fa85c3</originalsourceid><addsrcrecordid>eNqVkcGO0zAQhi0EWsrCIyBFCHFL8DRx4nBACxWwSCvBAc7WxJlsXTlxiF1objwCz8iT4NCqwBEfPKP5vxmP_DP2BHgG8TzfZVBUZSpyCRnU9ToLDRTrUmaHO2x1lu6yFee8SgGkvM8eeL_jPIqVuGAXkFc58PWK4WYObpxcIB2MG5JmToxdCj4keItmiHHECTUF7J39-f2HGdq9pjYJ7mC0CZEfki32PtCUGO8shihuacTg9BzIP2T3OrSeHp3iJfv89s2nzXV68-Hd-82rm1THZWXataARypo3RK3INXCgpsOCYr3qYugKFBgvqUlwIaQooBWRyHmHUuj8kr08zh33TU-tpiFMaNU4mR6nWTk06l9lMFt1674qqLksSx4HPDsNmNyXPfmgeuM1WYsDub1XUIKsoRARfHEEdfwmP1F3fgS4WgxSO7W4oBYX1GKQOhmkDrH58d9r_mk9OhL1pycdvUbbTTho48-YgHpdFRCxqyP2zVia_2MB9frj9e80_wVabbQV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16189145</pqid></control><display><type>article</type><title>Cytoprotection by iloprost against paracetamol‐induced toxicity in hamster isolated hepatocytes</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Nasseri‐Sina, P. ; Fawthrop, D.J. ; Wilson, J. ; Boobis, A.R. ; Davies, D.S.</creator><creatorcontrib>Nasseri‐Sina, P. ; Fawthrop, D.J. ; Wilson, J. ; Boobis, A.R. ; Davies, D.S.</creatorcontrib><description>1 The ability of iloprost (ZK36374) to protect hamster isolated hepatocytes from the toxic effects of paracetamol and its reactive metabolite N‐acetyl‐p‐benzoquinoneimine (NABQI) was investigated. The cytoprotection provided by iloprost was compared with that of N‐acetyl‐l‐cysteine. 2 Treatment of hepatocytes with either NABQI (0.4 mm) or paracetamol (2 mm) alone resulted in a considerable loss of cell viability, as assessed by trypan blue exclusion or leakage of lactate dehydrogenase, accompanied by an increase in the percentage of viable cells that were blebbed. N‐acetyl‐l‐cysteine (1.25 mm) pretreatment diminished the loss of cell viability and the percentage of blebbed cells resulting from exposure to NABQI or paracetamol, whereas iloprost (10−16 m to 10−10 m) pretreatment reduced only the loss of cell viability, not the percentage of viable cells exhibiting blebbing. Pretreatment with N‐acetyl‐l‐cysteine significantly attenuated the depletion by paracetamol of glutathione and decreased the covalent binding of [14C]‐paracetamol to cellular proteins, whereas iloprost was without any such effects. 3 The effects of iloprost and N‐acetyl‐l‐cysteine were also investigated by use of a model of paracetamol toxicity in which it is possible to study the biochemical events leading to cell injury separate from the generation of toxic metabolites. Hamster hepatocytes were incubated with paracetamol (4 mm) for 90 min at 37°C during which metabolism of paracetamol occurs with minimal loss of cell viability. Following washing of cells, to remove paracetamol and its metabolites, there was a progressive loss of viability and increase in the percentage of cells exhibiting blebbing when incubated in buffer alone. Addition of either N‐acetyl‐l‐cysteine (1.25 mm) or iloprost (10−14 m to 10−8 m), following washing, significantly reduced the expected loss of cell viability. Iloprost at concentrations outside this range was without effect. 4 Paracetamol toxicity to isolated hepatocytes could be prevented or delayed by treatment with either N‐acetyl‐l‐cysteine or iloprost, but whereas the former prevented or even reversed plasma membrane blebbing with a resultant reduction in the percentage of viable cells that were blebbed, the prostanoid appeared only to delay the progression from plasma membrane blebbing to loss of viability. Hence, the percentage of viable cells that were ultimately blebbed following exposure to paracetamol was not significantly reduced by addition of iloprost. 5 Aspirin or ibuprofen exacerbated the loss of viability induced by prior incubation with paracetamol. Thus, there may be a role for endogenous prostaglandins in protecting hepatocytes from paracetamol toxicity. 6 Iloprost is cytoprotective without any effect upon toxin metabolism or detoxication. The mechanism of action of iloprost probably does not involve induction of prostaglandin synthesis or activation of the previously‐characterized prostacyclin receptor.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1992.tb14268.x</identifier><identifier>PMID: 1373102</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acetaminophen - antagonists &amp; inhibitors ; Acetaminophen - toxicity ; Acetylcysteine - pharmacology ; Animals ; Benzoquinones - toxicity ; Biological and medical sciences ; Cell Survival - drug effects ; Cricetinae ; Cytoprotection ; Drug toxicity and drugs side effects treatment ; Glutathione - metabolism ; hepatocytes ; iloprost ; Iloprost - pharmacology ; Imines - toxicity ; In Vitro Techniques ; L-Lactate Dehydrogenase - metabolism ; Liver - cytology ; Liver - drug effects ; Male ; Medical sciences ; Mesocricetus ; paracetamol ; Pharmacology. Drug treatments ; Prostaglandin Antagonists - pharmacology ; prostaglandins ; Prostaglandins - biosynthesis ; toxicity ; Toxicity: digestive system</subject><ispartof>British journal of pharmacology, 1992-02, Vol.105 (2), p.417-423</ispartof><rights>1992 British Pharmacological Society</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5388-fd1ca1690beed53c101ebfa4ed1c7f4edf4a5af4a8ce50558541d5bfa30fa85c3</citedby><cites>FETCH-LOGICAL-c5388-fd1ca1690beed53c101ebfa4ed1c7f4edf4a5af4a8ce50558541d5bfa30fa85c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908660/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908660/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5192741$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1373102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nasseri‐Sina, P.</creatorcontrib><creatorcontrib>Fawthrop, D.J.</creatorcontrib><creatorcontrib>Wilson, J.</creatorcontrib><creatorcontrib>Boobis, A.R.</creatorcontrib><creatorcontrib>Davies, D.S.</creatorcontrib><title>Cytoprotection by iloprost against paracetamol‐induced toxicity in hamster isolated hepatocytes</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 The ability of iloprost (ZK36374) to protect hamster isolated hepatocytes from the toxic effects of paracetamol and its reactive metabolite N‐acetyl‐p‐benzoquinoneimine (NABQI) was investigated. The cytoprotection provided by iloprost was compared with that of N‐acetyl‐l‐cysteine. 2 Treatment of hepatocytes with either NABQI (0.4 mm) or paracetamol (2 mm) alone resulted in a considerable loss of cell viability, as assessed by trypan blue exclusion or leakage of lactate dehydrogenase, accompanied by an increase in the percentage of viable cells that were blebbed. N‐acetyl‐l‐cysteine (1.25 mm) pretreatment diminished the loss of cell viability and the percentage of blebbed cells resulting from exposure to NABQI or paracetamol, whereas iloprost (10−16 m to 10−10 m) pretreatment reduced only the loss of cell viability, not the percentage of viable cells exhibiting blebbing. Pretreatment with N‐acetyl‐l‐cysteine significantly attenuated the depletion by paracetamol of glutathione and decreased the covalent binding of [14C]‐paracetamol to cellular proteins, whereas iloprost was without any such effects. 3 The effects of iloprost and N‐acetyl‐l‐cysteine were also investigated by use of a model of paracetamol toxicity in which it is possible to study the biochemical events leading to cell injury separate from the generation of toxic metabolites. Hamster hepatocytes were incubated with paracetamol (4 mm) for 90 min at 37°C during which metabolism of paracetamol occurs with minimal loss of cell viability. Following washing of cells, to remove paracetamol and its metabolites, there was a progressive loss of viability and increase in the percentage of cells exhibiting blebbing when incubated in buffer alone. Addition of either N‐acetyl‐l‐cysteine (1.25 mm) or iloprost (10−14 m to 10−8 m), following washing, significantly reduced the expected loss of cell viability. Iloprost at concentrations outside this range was without effect. 4 Paracetamol toxicity to isolated hepatocytes could be prevented or delayed by treatment with either N‐acetyl‐l‐cysteine or iloprost, but whereas the former prevented or even reversed plasma membrane blebbing with a resultant reduction in the percentage of viable cells that were blebbed, the prostanoid appeared only to delay the progression from plasma membrane blebbing to loss of viability. Hence, the percentage of viable cells that were ultimately blebbed following exposure to paracetamol was not significantly reduced by addition of iloprost. 5 Aspirin or ibuprofen exacerbated the loss of viability induced by prior incubation with paracetamol. Thus, there may be a role for endogenous prostaglandins in protecting hepatocytes from paracetamol toxicity. 6 Iloprost is cytoprotective without any effect upon toxin metabolism or detoxication. The mechanism of action of iloprost probably does not involve induction of prostaglandin synthesis or activation of the previously‐characterized prostacyclin receptor.</description><subject>Acetaminophen - antagonists &amp; inhibitors</subject><subject>Acetaminophen - toxicity</subject><subject>Acetylcysteine - pharmacology</subject><subject>Animals</subject><subject>Benzoquinones - toxicity</subject><subject>Biological and medical sciences</subject><subject>Cell Survival - drug effects</subject><subject>Cricetinae</subject><subject>Cytoprotection</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Glutathione - metabolism</subject><subject>hepatocytes</subject><subject>iloprost</subject><subject>Iloprost - pharmacology</subject><subject>Imines - toxicity</subject><subject>In Vitro Techniques</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Liver - cytology</subject><subject>Liver - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mesocricetus</subject><subject>paracetamol</subject><subject>Pharmacology. Drug treatments</subject><subject>Prostaglandin Antagonists - pharmacology</subject><subject>prostaglandins</subject><subject>Prostaglandins - biosynthesis</subject><subject>toxicity</subject><subject>Toxicity: digestive system</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkcGO0zAQhi0EWsrCIyBFCHFL8DRx4nBACxWwSCvBAc7WxJlsXTlxiF1objwCz8iT4NCqwBEfPKP5vxmP_DP2BHgG8TzfZVBUZSpyCRnU9ToLDRTrUmaHO2x1lu6yFee8SgGkvM8eeL_jPIqVuGAXkFc58PWK4WYObpxcIB2MG5JmToxdCj4keItmiHHECTUF7J39-f2HGdq9pjYJ7mC0CZEfki32PtCUGO8shihuacTg9BzIP2T3OrSeHp3iJfv89s2nzXV68-Hd-82rm1THZWXataARypo3RK3INXCgpsOCYr3qYugKFBgvqUlwIaQooBWRyHmHUuj8kr08zh33TU-tpiFMaNU4mR6nWTk06l9lMFt1674qqLksSx4HPDsNmNyXPfmgeuM1WYsDub1XUIKsoRARfHEEdfwmP1F3fgS4WgxSO7W4oBYX1GKQOhmkDrH58d9r_mk9OhL1pycdvUbbTTho48-YgHpdFRCxqyP2zVia_2MB9frj9e80_wVabbQV</recordid><startdate>199202</startdate><enddate>199202</enddate><creator>Nasseri‐Sina, P.</creator><creator>Fawthrop, D.J.</creator><creator>Wilson, J.</creator><creator>Boobis, A.R.</creator><creator>Davies, D.S.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>199202</creationdate><title>Cytoprotection by iloprost against paracetamol‐induced toxicity in hamster isolated hepatocytes</title><author>Nasseri‐Sina, P. ; Fawthrop, D.J. ; Wilson, J. ; Boobis, A.R. ; Davies, D.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5388-fd1ca1690beed53c101ebfa4ed1c7f4edf4a5af4a8ce50558541d5bfa30fa85c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Acetaminophen - antagonists &amp; inhibitors</topic><topic>Acetaminophen - toxicity</topic><topic>Acetylcysteine - pharmacology</topic><topic>Animals</topic><topic>Benzoquinones - toxicity</topic><topic>Biological and medical sciences</topic><topic>Cell Survival - drug effects</topic><topic>Cricetinae</topic><topic>Cytoprotection</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Glutathione - metabolism</topic><topic>hepatocytes</topic><topic>iloprost</topic><topic>Iloprost - pharmacology</topic><topic>Imines - toxicity</topic><topic>In Vitro Techniques</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Liver - cytology</topic><topic>Liver - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mesocricetus</topic><topic>paracetamol</topic><topic>Pharmacology. Drug treatments</topic><topic>Prostaglandin Antagonists - pharmacology</topic><topic>prostaglandins</topic><topic>Prostaglandins - biosynthesis</topic><topic>toxicity</topic><topic>Toxicity: digestive system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nasseri‐Sina, P.</creatorcontrib><creatorcontrib>Fawthrop, D.J.</creatorcontrib><creatorcontrib>Wilson, J.</creatorcontrib><creatorcontrib>Boobis, A.R.</creatorcontrib><creatorcontrib>Davies, D.S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nasseri‐Sina, P.</au><au>Fawthrop, D.J.</au><au>Wilson, J.</au><au>Boobis, A.R.</au><au>Davies, D.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytoprotection by iloprost against paracetamol‐induced toxicity in hamster isolated hepatocytes</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1992-02</date><risdate>1992</risdate><volume>105</volume><issue>2</issue><spage>417</spage><epage>423</epage><pages>417-423</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 The ability of iloprost (ZK36374) to protect hamster isolated hepatocytes from the toxic effects of paracetamol and its reactive metabolite N‐acetyl‐p‐benzoquinoneimine (NABQI) was investigated. The cytoprotection provided by iloprost was compared with that of N‐acetyl‐l‐cysteine. 2 Treatment of hepatocytes with either NABQI (0.4 mm) or paracetamol (2 mm) alone resulted in a considerable loss of cell viability, as assessed by trypan blue exclusion or leakage of lactate dehydrogenase, accompanied by an increase in the percentage of viable cells that were blebbed. N‐acetyl‐l‐cysteine (1.25 mm) pretreatment diminished the loss of cell viability and the percentage of blebbed cells resulting from exposure to NABQI or paracetamol, whereas iloprost (10−16 m to 10−10 m) pretreatment reduced only the loss of cell viability, not the percentage of viable cells exhibiting blebbing. Pretreatment with N‐acetyl‐l‐cysteine significantly attenuated the depletion by paracetamol of glutathione and decreased the covalent binding of [14C]‐paracetamol to cellular proteins, whereas iloprost was without any such effects. 3 The effects of iloprost and N‐acetyl‐l‐cysteine were also investigated by use of a model of paracetamol toxicity in which it is possible to study the biochemical events leading to cell injury separate from the generation of toxic metabolites. Hamster hepatocytes were incubated with paracetamol (4 mm) for 90 min at 37°C during which metabolism of paracetamol occurs with minimal loss of cell viability. Following washing of cells, to remove paracetamol and its metabolites, there was a progressive loss of viability and increase in the percentage of cells exhibiting blebbing when incubated in buffer alone. Addition of either N‐acetyl‐l‐cysteine (1.25 mm) or iloprost (10−14 m to 10−8 m), following washing, significantly reduced the expected loss of cell viability. Iloprost at concentrations outside this range was without effect. 4 Paracetamol toxicity to isolated hepatocytes could be prevented or delayed by treatment with either N‐acetyl‐l‐cysteine or iloprost, but whereas the former prevented or even reversed plasma membrane blebbing with a resultant reduction in the percentage of viable cells that were blebbed, the prostanoid appeared only to delay the progression from plasma membrane blebbing to loss of viability. Hence, the percentage of viable cells that were ultimately blebbed following exposure to paracetamol was not significantly reduced by addition of iloprost. 5 Aspirin or ibuprofen exacerbated the loss of viability induced by prior incubation with paracetamol. Thus, there may be a role for endogenous prostaglandins in protecting hepatocytes from paracetamol toxicity. 6 Iloprost is cytoprotective without any effect upon toxin metabolism or detoxication. The mechanism of action of iloprost probably does not involve induction of prostaglandin synthesis or activation of the previously‐characterized prostacyclin receptor.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1373102</pmid><doi>10.1111/j.1476-5381.1992.tb14268.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1992-02, Vol.105 (2), p.417-423
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908660
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Acetaminophen - antagonists & inhibitors
Acetaminophen - toxicity
Acetylcysteine - pharmacology
Animals
Benzoquinones - toxicity
Biological and medical sciences
Cell Survival - drug effects
Cricetinae
Cytoprotection
Drug toxicity and drugs side effects treatment
Glutathione - metabolism
hepatocytes
iloprost
Iloprost - pharmacology
Imines - toxicity
In Vitro Techniques
L-Lactate Dehydrogenase - metabolism
Liver - cytology
Liver - drug effects
Male
Medical sciences
Mesocricetus
paracetamol
Pharmacology. Drug treatments
Prostaglandin Antagonists - pharmacology
prostaglandins
Prostaglandins - biosynthesis
toxicity
Toxicity: digestive system
title Cytoprotection by iloprost against paracetamol‐induced toxicity in hamster isolated hepatocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T21%3A42%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytoprotection%20by%20iloprost%20against%20paracetamol%E2%80%90induced%20toxicity%20in%20hamster%20isolated%20hepatocytes&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Nasseri%E2%80%90Sina,%20P.&rft.date=1992-02&rft.volume=105&rft.issue=2&rft.spage=417&rft.epage=423&rft.pages=417-423&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1992.tb14268.x&rft_dat=%3Cproquest_pubme%3E16189145%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16189145&rft_id=info:pmid/1373102&rfr_iscdi=true